Safety and Efficacy of the S-ICD System : S-ICD shock efficacy
Almost 2 decades of clinical data have consistently demonstrated high overall shock efficacy and spontaneous conversion rates for the S-ICD.
First and final shock efficacy in EFFORTLESS Registry1
S-ICD has been shown to safely convert spontaneous arrhythmias. Data from the EFFORTLESS registry shows overall final shock efficacy of 98%, after 5 years of follow up.1
Spontaneous conversion efficacy in the ATLAS trial2
More recently, the ATLAS trial also demonstrated, the conversion efficacy of over 99%, at 6 months, for S-ICD2
Evidence from Four Randomized Studies
The high spontaneous conversion efficacy for S-ICD, demonstrated in over 4,000 patients across 4 randomized studies, is comparable to TV-ICD:1,3-9